91 related articles for article (PubMed ID: 2178354)
21. Genomic modifications in Sabin vaccine strains isolated from vaccination-associated cases, healthy contacts and healthy vaccinees.
Friedrich F
Acta Virol; 1996 Jun; 40(3):157-70. PubMed ID: 8891097
[TBL] [Abstract][Full Text] [Related]
22. Genetic basis of attenuation of the Sabin oral poliovirus vaccines.
Minor PD; Macadam AJ; Stone DM; Almond JW
Biologicals; 1993 Dec; 21(4):357-63. PubMed ID: 8024751
[No Abstract] [Full Text] [Related]
23. Genetic basis of attenuation of the Sabin type 2 vaccine strain of poliovirus in primates.
Macadam AJ; Pollard SR; Ferguson G; Skuce R; Wood D; Almond JW; Minor PD
Virology; 1993 Jan; 192(1):18-26. PubMed ID: 8390752
[TBL] [Abstract][Full Text] [Related]
24. Vaccine derived bi- and multi-recombinant Sabin strains.
Paximadi E; Karakasiliotis I; Bolanaki E; Krikelis A; Markoulatos P
Virus Genes; 2007 Dec; 35(3):541-8. PubMed ID: 17680217
[TBL] [Abstract][Full Text] [Related]
25. Studies on the genetic basis of attenuation of the Sabin type 3 poliovirus vaccine.
Almond JW; Westrop GD; Wareham KA; Skinner MA; Evans DM; Magrath D; Schild GC; Minor PD
Biochem Soc Symp; 1987; 53():85-90. PubMed ID: 2847743
[No Abstract] [Full Text] [Related]
26. New assays for the quality control of live oral poliovirus vaccine.
Furesz J; Levenbook I
Acta Microbiol Immunol Hung; 1998; 45(3-4):391-9. PubMed ID: 9873944
[TBL] [Abstract][Full Text] [Related]
27. Studies on neurovirulence in poliovirus-sensitive transgenic mice and cynomolgus monkeys for the different temperature-sensitive viruses derived from the Sabin type 3 virus.
Abe S; Ota Y; Doi Y; Nomoto A; Nomura T; Chumakov KM; Hashizume S
Virology; 1995 Jun; 210(1):160-6. PubMed ID: 7793068
[TBL] [Abstract][Full Text] [Related]
28. Retrospective molecular and phenotypic analysis of poliovirus vaccine strains isolated in Greece.
Pliaka V; Filliponi ME; Kyriakopoulou Z; Ruether IG; Tsakogiannis D; Gartzonika C; Levidiotou-Stefanou S; Markoulatos P
Clin Microbiol Infect; 2011 Oct; 17(10):1554-62. PubMed ID: 21375661
[TBL] [Abstract][Full Text] [Related]
29. Approaches to the construction of new candidate poliovirus type 3 vaccine strains.
Almond JW; Stone D; Burke K; Skinner MA; Macadam AJ; Wood D; Ferguson M; Minor PD
Dev Biol Stand; 1993; 78():161-9; discussion 169-70. PubMed ID: 8388827
[TBL] [Abstract][Full Text] [Related]
30. Antigenic modification of attenuated Sabin type 1 poliovirus by in vitro passages at supraoptimal temperatures.
Crainic R; Blondel B; Candréa A; Dufraisse G; Horaud F
Dev Biol Stand; 1985; 60():343-7. PubMed ID: 2995173
[TBL] [Abstract][Full Text] [Related]
31. Molecular evolution of oral poliovirus vaccine strains during multiplication in humans and possible implications for global eradication of poliovirus.
Friedrich F
Acta Virol; 2000 Apr; 44(2):109-17. PubMed ID: 10989702
[TBL] [Abstract][Full Text] [Related]
32. Genetic stability and mutant selection in Sabin 2 strain of oral poliovirus vaccine grown under different cell culture conditions.
Taffs RE; Chumakov KM; Rezapkin GV; Lu Z; Douthitt M; Dragunsky EM; Levenbook IS
Virology; 1995 Jun; 209(2):366-73. PubMed ID: 7778271
[TBL] [Abstract][Full Text] [Related]
33. Determination of antigenic properties of vaccine derived poliovirus strains.
Pliaka V; Achilleos C; Kyriakopoulou Z; Tsakogiannis D; Ruether IG; Gartzonica C; Levidiotou-Stefanou S; Markoulatos P
Vaccine; 2010 Dec; 29(1):26-33. PubMed ID: 20974307
[TBL] [Abstract][Full Text] [Related]
34. Circulating type 1 vaccine-derived poliovirus may evolve under the pressure of adenosine deaminases acting on RNA.
Liu Y; Ma T; Liu J; Zhao X; Cheng Z; Guo H; Xu R; Wang S
J Matern Fetal Neonatal Med; 2015; 28(17):2096-9. PubMed ID: 25330844
[TBL] [Abstract][Full Text] [Related]
35. [Genetic evolution of poliovirus: success and difficulties in the eradication of paralytic poliomyelitis].
Blondel B; Autret A; Brisac C; Pelletier I; Martin-Latil S; Jegouic S; Bessaud M; Joffret ML; Balanant J; Colbère-Garapin F; Delpeyroux F
Med Trop (Mars); 2008 Apr; 68(2):189-202. PubMed ID: 18630055
[TBL] [Abstract][Full Text] [Related]
36. Engineering attenuated virus vaccines by controlling replication fidelity.
Vignuzzi M; Wendt E; Andino R
Nat Med; 2008 Feb; 14(2):154-61. PubMed ID: 18246077
[TBL] [Abstract][Full Text] [Related]
37. [Genetic recombination in vaccine poliovirus: comparative study in strains excreted in course of vaccination by oral poliovirus vaccine and circulating strains].
Haddad-Boubaker S; Ould-Mohamed-Abdallah MV; Ben-Yahia A; Triki H
Pathol Biol (Paris); 2010 Dec; 58(6):420-5. PubMed ID: 19299091
[TBL] [Abstract][Full Text] [Related]
38. Poliovirus attenuation and pathogenesis in a transgenic mouse model for poliomyelitis.
Racaniello VR; Ren R; Bouchard M
Dev Biol Stand; 1993; 78():109-16. PubMed ID: 8388820
[TBL] [Abstract][Full Text] [Related]
39. Nucleobase but not Sugar Fidelity is Maintained in the Sabin I RNA-Dependent RNA Polymerase.
Liu X; Musser DM; Lee CA; Yang X; Arnold JJ; Cameron CE; Boehr DD
Viruses; 2015 Oct; 7(10):5571-86. PubMed ID: 26516899
[TBL] [Abstract][Full Text] [Related]
40. Albert B. Sabin and the development of oral poliovaccine.
Horaud F
Biologicals; 1993 Dec; 21(4):311-6. PubMed ID: 8024745
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
